mexichem specialty compounds limited
mexichem specialty compounds limited Company Information
Company Number
01572669
Next Accounts
Sep 2025
Shareholders
mexichem resinas vinilicas s.a. de c.v.
Group Structure
View All
Industry
Manufacture of plastics in primary forms
+1Registered Address
c/o mexichem 8 beler way, leicester road industrial estate, melton mowbray, leicestershire, LE13 0DG
mexichem specialty compounds limited Estimated Valuation
Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £61.7m based on a Turnover of £79.4m and 0.78x industry multiple (adjusted for size and gross margin).
mexichem specialty compounds limited Estimated Valuation
Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £12.5m based on an EBITDA of £2.2m and a 5.81x industry multiple (adjusted for size and gross margin).
mexichem specialty compounds limited Estimated Valuation
Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £279.5m based on Net Assets of £161.8m and 1.73x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mexichem Specialty Compounds Limited Overview
Mexichem Specialty Compounds Limited is a live company located in melton mowbray, LE13 0DG with a Companies House number of 01572669. It operates in the manufacture of plastics in primary forms sector, SIC Code 20160. Founded in July 1981, it's largest shareholder is mexichem resinas vinilicas s.a. de c.v. with a 100% stake. Mexichem Specialty Compounds Limited is a mature, large sized company, Pomanda has estimated its turnover at £79.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mexichem Specialty Compounds Limited Health Check
Pomanda's financial health check has awarded Mexichem Specialty Compounds Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £79.4m, make it larger than the average company (£19.9m)
£79.4m - Mexichem Specialty Compounds Limited
£19.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (7%)
-4% - Mexichem Specialty Compounds Limited
7% - Industry AVG
Production
with a gross margin of 17.1%, this company has a higher cost of product (22.3%)
17.1% - Mexichem Specialty Compounds Limited
22.3% - Industry AVG
Profitability
an operating margin of -0.6% make it less profitable than the average company (4.9%)
-0.6% - Mexichem Specialty Compounds Limited
4.9% - Industry AVG
Employees
with 227 employees, this is above the industry average (86)
227 - Mexichem Specialty Compounds Limited
86 - Industry AVG
Pay Structure
on an average salary of £50.4k, the company has an equivalent pay structure (£42.9k)
£50.4k - Mexichem Specialty Compounds Limited
£42.9k - Industry AVG
Efficiency
resulting in sales per employee of £349.7k, this is more efficient (£249.9k)
£349.7k - Mexichem Specialty Compounds Limited
£249.9k - Industry AVG
Debtor Days
it gets paid by customers after 43 days, this is near the average (46 days)
43 days - Mexichem Specialty Compounds Limited
46 days - Industry AVG
Creditor Days
its suppliers are paid after 58 days, this is slower than average (34 days)
58 days - Mexichem Specialty Compounds Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 42 days, this is less than average (54 days)
42 days - Mexichem Specialty Compounds Limited
54 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 62 weeks, this is more cash available to meet short term requirements (11 weeks)
62 weeks - Mexichem Specialty Compounds Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 9%, this is a lower level of debt than the average (40.6%)
9% - Mexichem Specialty Compounds Limited
40.6% - Industry AVG
MEXICHEM SPECIALTY COMPOUNDS LIMITED financials
Mexichem Specialty Compounds Limited's latest turnover from December 2023 is £79.4 million and the company has net assets of £161.8 million. According to their latest financial statements, Mexichem Specialty Compounds Limited has 227 employees and maintains cash reserves of £13.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Jan 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 79,390,000 | 107,139,000 | 98,614,000 | 90,336,000 | 107,089,000 | 99,971,000 | 60,837,000 | 46,384,000 | 42,139,000 | 47,391,000 | 45,491,000 | 53,006,000 | 45,060,000 | 44,185,000 | 36,668,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 65,848,000 | 90,549,000 | 83,907,000 | 77,111,000 | 88,330,000 | 80,016,000 | 50,225,000 | 38,039,000 | 36,145,000 | 41,203,000 | 38,636,000 | 46,247,000 | 37,774,000 | 36,329,000 | 30,507,000 |
| Gross Profit | 13,542,000 | 16,590,000 | 14,707,000 | 13,225,000 | 18,759,000 | 19,955,000 | 10,612,000 | 8,345,000 | 5,994,000 | 6,188,000 | 6,855,000 | 6,759,000 | 7,286,000 | 7,856,000 | 6,161,000 |
| Admin Expenses | 14,021,000 | 13,373,000 | 13,883,000 | 3,778,000 | 12,737,000 | 11,297,000 | 8,364,000 | 7,605,000 | 7,711,000 | 9,952,000 | 7,566,000 | 7,951,000 | 7,558,000 | 6,591,000 | 5,403,000 |
| Operating Profit | -479,000 | 3,217,000 | 824,000 | 9,447,000 | 6,022,000 | 8,658,000 | 2,248,000 | 740,000 | -1,717,000 | -3,764,000 | -711,000 | -1,192,000 | -272,000 | 1,265,000 | 758,000 |
| Interest Payable | 144,000 | 233,000 | 224,000 | 190,000 | 597,000 | 18,000 | 25,000 | ||||||||
| Interest Receivable | 369,000 | 323,000 | 345,000 | 404,000 | 606,000 | 587,000 | 247,000 | 345,000 | 316,000 | 61,000 | 12,000 | 3,000 | 11,000 | 7,000 | 18,000 |
| Pre-Tax Profit | -254,000 | 3,307,000 | 945,000 | 9,241,000 | 5,401,000 | 22,566,000 | 11,072,000 | 2,282,000 | -1,612,000 | -3,908,000 | -703,000 | -1,268,000 | -729,000 | 4,331,000 | 751,000 |
| Tax | 298,000 | -1,076,000 | -89,000 | -631,000 | -870,000 | -1,751,000 | -411,000 | -103,000 | 332,000 | 67,000 | 394,000 | 454,000 | 299,000 | -1,006,000 | -239,000 |
| Profit After Tax | 44,000 | 2,231,000 | 856,000 | 8,610,000 | 4,531,000 | 20,815,000 | 10,661,000 | 2,179,000 | -1,280,000 | -3,841,000 | -309,000 | -814,000 | -430,000 | 3,325,000 | 512,000 |
| Dividends Paid | 3,173,000 | ||||||||||||||
| Retained Profit | 44,000 | 2,231,000 | 856,000 | 8,610,000 | 1,358,000 | 7,249,000 | 1,713,000 | 2,179,000 | -1,280,000 | -3,841,000 | -309,000 | -814,000 | -430,000 | 3,325,000 | 512,000 |
| Employee Costs | 11,450,000 | 11,982,000 | 11,401,000 | 10,208,000 | 10,240,000 | 9,345,000 | 5,620,000 | 4,643,000 | 4,714,000 | 4,323,000 | 4,588,000 | 4,558,000 | 4,455,000 | 4,643,000 | 4,317,000 |
| Number Of Employees | 227 | 248 | 251 | 248 | 234 | 220 | 140 | 114 | 121 | 117 | 113 | 115 | 120 | 120 | 129 |
| EBITDA* | 2,153,000 | 5,787,000 | 4,488,000 | 12,880,000 | 8,671,000 | 10,943,000 | 4,055,000 | 2,470,000 | 145,000 | -1,337,000 | 1,748,000 | 1,295,000 | 2,110,000 | 3,541,000 | 3,202,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Jan 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 18,588,000 | 159,929,000 | 164,974,000 | 139,179,000 | 137,765,000 | 135,945,000 | 131,210,000 | 126,648,000 | 127,694,000 | 116,119,000 | 17,147,000 | 18,618,000 | 20,190,000 | 21,658,000 | 22,814,000 |
| Intangible Assets | 2,363,000 | 87,000 | 117,000 | 616,000 | 1,257,000 | 1,878,000 | 2,430,000 | 3,003,000 | 3,633,000 | 4,305,000 | 4,981,000 | 5,648,000 | 6,330,000 | 6,714,000 | 10,056,000 |
| Investments & Other | 116,129,000 | 116,129,000 | 112,966,000 | 112,966,000 | 112,965,000 | 112,965,000 | 112,965,000 | 112,965,000 | 112,965,000 | 100,502,000 | |||||
| Debtors (Due After 1 year) | 5,891,000 | 10,778,000 | 14,059,000 | ||||||||||||
| Total Fixed Assets | 142,971,000 | 149,238,000 | 151,032,000 | 139,795,000 | 139,022,000 | 137,823,000 | 133,640,000 | 129,651,000 | 131,327,000 | 120,424,000 | 22,128,000 | 24,266,000 | 26,520,000 | 28,372,000 | 32,870,000 |
| Stock & work in progress | 7,674,000 | 11,577,000 | 14,252,000 | 11,521,000 | 14,804,000 | 18,792,000 | 14,966,000 | 6,116,000 | 5,151,000 | 6,854,000 | 8,059,000 | 6,607,000 | 7,588,000 | 6,532,000 | 5,888,000 |
| Trade Debtors | 9,425,000 | 14,155,000 | 17,979,000 | 15,994,000 | 14,134,000 | 17,173,000 | 16,921,000 | 8,994,000 | 7,060,000 | 6,750,000 | 6,789,000 | 6,815,000 | 8,354,000 | 6,846,000 | |
| Group Debtors | 2,623,000 | 2,003,000 | 1,932,000 | 12,283,000 | 13,404,000 | 13,125,000 | 393,000 | 6,115,000 | 5,181,000 | 4,246,000 | 1,744,000 | 1,280,000 | 334,000 | 44,000 | 946,000 |
| Misc Debtors | 1,504,000 | 744,000 | 713,000 | 739,000 | 1,154,000 | 1,269,000 | 1,189,000 | 389,000 | 689,000 | 794,000 | 516,000 | 374,000 | 549,000 | 7,894,000 | 1,284,000 |
| Cash | 13,555,000 | 11,264,000 | 3,348,000 | 6,126,000 | 7,534,000 | 6,925,000 | 17,647,000 | 1,484,000 | 1,555,000 | 4,829,000 | 5,226,000 | 4,347,000 | 4,554,000 | 1,449,000 | 2,513,000 |
| misc current assets | 125,000 | 125,000 | |||||||||||||
| total current assets | 34,781,000 | 40,279,000 | 39,057,000 | 47,828,000 | 51,933,000 | 57,284,000 | 51,116,000 | 23,098,000 | 19,636,000 | 23,473,000 | 22,334,000 | 19,548,000 | 21,504,000 | 15,919,000 | 17,477,000 |
| total assets | 177,752,000 | 189,517,000 | 190,089,000 | 187,623,000 | 190,955,000 | 195,107,000 | 184,756,000 | 152,749,000 | 150,963,000 | 143,897,000 | 44,462,000 | 43,814,000 | 48,024,000 | 44,291,000 | 50,347,000 |
| Bank overdraft | 23,358,000 | ||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 10,629,000 | 9,177,000 | 11,234,000 | 11,230,000 | 10,144,000 | 9,700,000 | 7,340,000 | 5,709,000 | 7,016,000 | 10,190,000 | 8,190,000 | 5,485,000 | 5,867,000 | 4,495,000 | 5,184,000 |
| Group/Directors Accounts | 198,000 | ||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 668,000 | 712,000 | 670,000 | 638,000 | 391,000 | ||||||||||
| other current liabilities | 12,537,000 | 17,418,000 | 15,216,000 | 22,692,000 | 30,299,000 | 30,203,000 | 1,968,000 | 1,169,000 | 1,782,000 | 1,875,000 | 1,229,000 | 3,790,000 | 698,000 | 731,000 | |
| total current liabilities | 11,297,000 | 22,426,000 | 29,322,000 | 27,084,000 | 33,227,000 | 39,999,000 | 37,543,000 | 7,677,000 | 8,185,000 | 11,972,000 | 10,065,000 | 6,714,000 | 9,657,000 | 5,193,000 | 29,471,000 |
| loans | 5,164,000 | 6,034,000 | 7,164,000 | 3,326,000 | |||||||||||
| hp & lease commitments | 1,930,000 | 2,582,000 | 3,017,000 | 3,582,000 | 1,663,000 | ||||||||||
| Accruals and Deferred Income | 2,617,000 | 1,907,000 | |||||||||||||
| other liabilities | 25,000 | 169,000 | 101,000 | 30,000 | 28,000 | 38,000 | 6,000 | 15,000 | 4,000 | ||||||
| provisions | 2,734,000 | 4,082,000 | 3,562,000 | 4,344,000 | 3,116,000 | 2,242,000 | 2,034,000 | 2,698,000 | 2,832,000 | 3,620,000 | 4,524,000 | 5,126,000 | |||
| total long term liabilities | 4,689,000 | 5,368,000 | 5,025,000 | 5,653,000 | 3,472,000 | 2,210,000 | 1,564,000 | 1,136,000 | 1,021,000 | 1,349,000 | 1,416,000 | 1,810,000 | 2,262,000 | 2,563,000 | |
| total liabilities | 15,986,000 | 27,794,000 | 34,347,000 | 32,737,000 | 36,699,000 | 42,209,000 | 39,107,000 | 8,813,000 | 9,206,000 | 13,321,000 | 11,481,000 | 8,524,000 | 11,919,000 | 7,756,000 | 29,471,000 |
| net assets | 161,766,000 | 161,723,000 | 155,742,000 | 154,886,000 | 154,256,000 | 152,898,000 | 145,649,000 | 143,936,000 | 141,757,000 | 130,576,000 | 32,981,000 | 35,290,000 | 36,105,000 | 36,535,000 | 20,876,000 |
| total shareholders funds | 161,766,000 | 161,723,000 | 155,742,000 | 154,886,000 | 154,256,000 | 152,898,000 | 145,649,000 | 143,936,000 | 141,757,000 | 130,576,000 | 32,981,000 | 35,290,000 | 36,105,000 | 36,535,000 | 20,876,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Jan 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -479,000 | 3,217,000 | 824,000 | 9,447,000 | 6,022,000 | 8,658,000 | 2,248,000 | 740,000 | -1,717,000 | -3,764,000 | -711,000 | -1,192,000 | -272,000 | 1,265,000 | 758,000 |
| Depreciation | 1,844,000 | 2,541,000 | 3,153,000 | 2,781,000 | 2,008,000 | 1,660,000 | 1,182,000 | 1,081,000 | 1,182,000 | 1,751,000 | 1,784,000 | 1,805,000 | 1,742,000 | 1,618,000 | 1,853,000 |
| Amortisation | 788,000 | 29,000 | 511,000 | 652,000 | 641,000 | 625,000 | 625,000 | 649,000 | 680,000 | 676,000 | 675,000 | 682,000 | 640,000 | 658,000 | 591,000 |
| Tax | 298,000 | -1,076,000 | -89,000 | -631,000 | -870,000 | -1,751,000 | -411,000 | -103,000 | 332,000 | 67,000 | 394,000 | 454,000 | 299,000 | -1,006,000 | -239,000 |
| Stock | -3,903,000 | -2,675,000 | 2,731,000 | -3,283,000 | -3,988,000 | 3,826,000 | 8,850,000 | 965,000 | -1,703,000 | -1,205,000 | 1,452,000 | -981,000 | 7,588,000 | 6,532,000 | 5,888,000 |
| Debtors | -8,237,000 | -7,003,000 | 5,667,000 | 324,000 | -2,875,000 | 13,064,000 | 3,005,000 | 2,568,000 | 1,140,000 | 2,741,000 | 580,000 | -768,000 | 9,237,000 | 7,938,000 | 9,076,000 |
| Creditors | 1,452,000 | -2,057,000 | 4,000 | 1,086,000 | 444,000 | 2,360,000 | 1,631,000 | -1,307,000 | -3,174,000 | 2,000,000 | 2,705,000 | -382,000 | 5,867,000 | 4,495,000 | 5,184,000 |
| Accruals and Deferred Income | -15,154,000 | -4,171,000 | 4,109,000 | -7,476,000 | -7,607,000 | 96,000 | 28,235,000 | 799,000 | -613,000 | -93,000 | 646,000 | -2,561,000 | 3,790,000 | 698,000 | 731,000 |
| Deferred Taxes & Provisions | 2,734,000 | -4,082,000 | 520,000 | -782,000 | 1,228,000 | 874,000 | 208,000 | -664,000 | -134,000 | -788,000 | -904,000 | 4,524,000 | 5,126,000 | ||
| Cash flow from operations | 3,623,000 | 8,161,000 | -3,968,000 | 9,338,000 | 6,719,000 | -4,014,000 | 22,529,000 | -1,466,000 | -3,411,000 | -1,033,000 | 2,673,000 | -349,000 | -235,000 | -1,616,000 | -6,086,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 3,163,000 | 1,000 | 12,463,000 | 100,502,000 | |||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 198,000 | ||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -5,164,000 | -870,000 | -1,130,000 | 3,838,000 | 3,326,000 | ||||||||||
| Hire Purchase and Lease Commitments | -696,000 | -393,000 | -533,000 | 2,166,000 | 2,054,000 | ||||||||||
| other long term liabilities | -144,000 | 68,000 | 71,000 | 2,000 | -10,000 | 32,000 | -9,000 | 11,000 | 4,000 | ||||||
| share issue | |||||||||||||||
| interest | 225,000 | 90,000 | 121,000 | 214,000 | 9,000 | 587,000 | 247,000 | 345,000 | 316,000 | 61,000 | 12,000 | 3,000 | 11,000 | -11,000 | -7,000 |
| cash flow from financing | -5,780,000 | 2,645,000 | -1,471,000 | -1,760,000 | 5,379,000 | 619,000 | 238,000 | 356,000 | 12,781,000 | 101,497,000 | -1,988,000 | 2,000 | 36,546,000 | 33,199,000 | 20,555,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 2,291,000 | 7,916,000 | -2,778,000 | -1,408,000 | 609,000 | -10,722,000 | 16,163,000 | -71,000 | -3,274,000 | -397,000 | 879,000 | -207,000 | 4,554,000 | 1,449,000 | 2,513,000 |
| overdraft | 23,358,000 | ||||||||||||||
| change in cash | 2,291,000 | 7,916,000 | -2,778,000 | -1,408,000 | 609,000 | -10,722,000 | 16,163,000 | -71,000 | -3,274,000 | -397,000 | 879,000 | -207,000 | 4,554,000 | 1,449,000 | -20,845,000 |
mexichem specialty compounds limited Credit Report and Business Information
Mexichem Specialty Compounds Limited Competitor Analysis
Perform a competitor analysis for mexichem specialty compounds limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in LE13 area or any other competitors across 12 key performance metrics.
mexichem specialty compounds limited Ownership
MEXICHEM SPECIALTY COMPOUNDS LIMITED group structure
Mexichem Specialty Compounds Limited has no subsidiary companies.
Ultimate parent company
ORBIA ADVANCE CORPORATION SAB DE CV
#0134191
MEXICHEM RESINAS VINILICAS SA DE CV
#0087841
2 parents
MEXICHEM SPECIALTY COMPOUNDS LIMITED
01572669
mexichem specialty compounds limited directors
Mexichem Specialty Compounds Limited currently has 3 directors. The longest serving directors include Mr Gautam Nivarthy (Jul 2018) and Mr Daniel Delisle (Jul 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Gautam Nivarthy | United States | 51 years | Jul 2018 | - | Director |
| Mr Daniel Delisle | United States | 59 years | Jul 2018 | - | Director |
| Mr William Musante | United States | 60 years | Jul 2022 | - | Director |
P&L
December 2023turnover
79.4m
-26%
operating profit
-479k
-115%
gross margin
17.1%
+10.16%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
161.8m
0%
total assets
177.8m
-0.06%
cash
13.6m
+0.2%
net assets
Total assets minus all liabilities
mexichem specialty compounds limited company details
company number
01572669
Type
Private limited with Share Capital
industry
20160 - Manufacture of plastics in primary forms
22290 - Manufacture of other plastic products
incorporation date
July 1981
age
44
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
alphagary limited (February 2016)
laporte alphagary limited (August 1999)
See moreaccountant
-
auditor
DELOITTE LLP
address
c/o mexichem 8 beler way, leicester road industrial estate, melton mowbray, leicestershire, LE13 0DG
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
mexichem specialty compounds limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to mexichem specialty compounds limited. Currently there are 0 open charges and 5 have been satisfied in the past.
mexichem specialty compounds limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEXICHEM SPECIALTY COMPOUNDS LIMITED. This can take several minutes, an email will notify you when this has completed.
mexichem specialty compounds limited Companies House Filings - See Documents
| date | description | view/download |
|---|
